LASAACI - Los Angeles Society of Allergy, Asthma & Clinical Immunology, Inc.


	ANNUAL MEETINGS

HOME

MISSION

MEMBERSHIP

ANNUAL MEETINGS

CME/CE INFORMATION
LINKS

ALLERGY/ASTHMA
INFORMATION TOPICS

LASAACI BOARD

LASAACI MEMBERS

CONTACT US

Fall Symposium 2009

The Los Angeles Society of Allergy, Asthma & Clinical Immunology, Inc., sponsors educational meetings that help promote best practices among clinicians caring for asthma and allergy patients.

Fall Symposium 2009 - Saturday, September 26, 2009

Program agenda included:

"Immune Response Modifiers in the Treatment of Allergic Diseases"
Mark Ballow, MD, State University of New York at Buffalo

"Asthma Masquerader"
Fernando J. Martinez, MD University of Michigan Health System

“Allergic Conjunctivitis" and "Chronic Rhinosinusitis and Nasal Polyposis"
Thomas B. Casale, MD, Creighton University Medical Center

“ABAI Maintenance of Certification for the Allergist for 2010 and Beyond”
Mark L. Corbett, MD, ABAI Maintenance of Certification Task Force

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Abbott Laboratories, Aerocrine, Inc., Alcon Laboratories, Inc., Allermed Laboratories, Apieron, Inc., Asthma & Allergy Foundation of America, California Chapter, AstraZeneca LP, Baxter Bioscience, Bioscrip, Biofusion, Crescent Home Health, CSL Behring, LLC, Dey LP, Genentech, GlaxoSmithKline, Greer, Hollister-Stier Laboratories LLC, IBT Laboratories, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mission Allergy, NeilMed Pharmaceuticals, Inc., Novartis, Nutricia North America, Inc., Octapharma, Sanofi-Aventis, Schering Plough, Sciele Pharma, Inc., Shier Human Genetic Therapies, South Coast Air Quality Management District, Talecris Biotherapeutics, TEVA Respiratory, LLC, UCB, Inc., US Bioservices, and ViroPharma Incorporated.